Bertrand Audoin Selected Research

Mitoxantrone (Novantrone)

7/2019

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bertrand Audoin Research Topics

Disease

19	Multiple Sclerosis 05/2024 - 07/2007
10	Neuromyelitis Optica (Devic's Disease) 01/2024 - 10/2015
4	Infections 01/2023 - 01/2020
3	COVID-19 01/2022 - 01/2020
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 10/2018 - 06/2011
2	Optic Neuritis (Retrobulbar Neuritis) 01/2023 - 01/2023
2	Osteosarcoma (Osteogenic Sarcoma) 09/2022 - 01/2019
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 01/2021
2	Myelitis 01/2022 - 01/2020
2	Transverse Myelitis (Necrotizing Myelitis) 04/2020 - 01/2020
2	Inflammation (Inflammations) 01/2019 - 07/2012
2	Relapsing-Remitting Multiple Sclerosis 01/2019 - 01/2017
1	Neoplasms (Cancer) 02/2024
1	Ganglion Cysts (Ganglion) 11/2023
1	Spontaneous Abortion (Miscarriage) 01/2023
1	Pain (Aches) 01/2022
1	Neuroinflammatory Diseases 06/2021
1	Necrosis 06/2021
1	Sarcoidosis (Schaumann Disease) 06/2021
1	Persistent Infection 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Cognitive Dysfunction 01/2017
1	Atrophy 01/2017
1	Neurologic Manifestations (Neurological Manifestations) 05/2016

Drug/Important Bio-Agent (IBA)

13	Rituximab (Mabthera)FDA Link 05/2024 - 10/2015
7	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2020
5	SodiumIBA 10/2022 - 09/2012
5	Immunoglobulin G (IgG)IBA 01/2022 - 09/2017
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2011
3	SteroidsIBA 01/2023 - 07/2012
3	AntibodiesIBA 01/2022 - 01/2020
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2021 - 07/2019
2	Fingolimod Hydrochloride (FTY720)FDA Link 05/2024 - 01/2022
2	ocrelizumabIBA 05/2024 - 01/2024
2	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2022
2	trans-sodium crocetinate (crocetin)IBA 01/2019 - 01/2017
2	miglustat (Zavesca)FDA Link 10/2018 - 05/2016
1	Retinaldehyde (Retinal)IBA 11/2023
1	VaccinesIBA 01/2023
1	nitazoxanide (NTZ)FDA Link 01/2023
1	Methyl MethanesulfonateIBA 09/2022
1	Oligoclonal BandsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Aquaporin 4IBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	BNT162 VaccineIBA 10/2021
1	Natalizumab (Tysabri)FDA Link 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Aquaporins (Water Channels)IBA 04/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2019
1	Methotrexate (Mexate)FDA LinkGeneric 07/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2019
1	PolymersIBA 01/2019
1	LipidsIBA 10/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2017
1	CholesterolIBA 05/2016
1	GlycosphingolipidsIBA 05/2016
1	GangliosidesIBA 05/2016
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2016
1	ferric oxide (iron oxide)IBA 01/2016
1	Immunoglobulin M (IgM)IBA 05/2012
1	GadoliniumIBA 07/2007
1	Protons (Proton)IBA 07/2007

Therapy/Procedure

10	Therapeutics 05/2024 - 06/2011
1	Plasma Exchange 01/2023
1	Immunotherapy 01/2022